By directly binding to the phosphoribosyl pyrophosphate aminotransferase (PPAT) active site of the protein, Tan I substantially curtailed the production of PPAT, thereby mitigating the PPAT-mediated carcinogenic response in radioresistant lung cancer cells (H358-IR and H157-IR). This evidence concerns the gene PPAT and lung carcinoma.